Facebook
X
LinkedIn
ForwardAll About Hypersomnia Congress 2025
Along with the congress chair, Dr Chad M. Ruoff, this congress features a faculty of 11 leading speakers who are specialists in hypersomnia. Each day there will be 3 presentations of 30-minute duration in the morning and 3 in the afternoon followed by a 30-minute discussion providing the opportunity for the audience to ask questions and reinforce learning. The morning and afternoon presentations will be followed by 2 case studies/special topics that will highlight the speaker’s clinical experiences or areas of special interest.
Target Audience
This activity is designed for an audience of physicians including sleep specialists/ sleep medicine doctors, neurologists, sleep technologists, respiratory therapist, nurse practitioners, physician associates and other healthcare providers.
Learning Objectives
- Apply current diagnostic criteria to differentiate narcolepsy and idiopathic hypersomnia in adults and children.
Utilize actigraphy, wearables, and biomarkers (e.g., CSF orexin) to enhance hypersomnia diagnosis. - Describe recent advances in the understanding of sleep-wake circuits, autonomics, and REM dysfunction.
- Develop personalized treatment plans for patients with narcolepsy and idiopathic hypersomnia.
- Use wearable data, patient reports, and clinical measures to monitor and optimize treatment outcomes.
Commercial Support
This activity is supported by independent medical education grants from Alkermes, Avadel CNS Pharmaceuticals, LLC, Axsome Therapeutics, Inc., Harmony Biosciences Management, Inc., Jazz Pharamaceuticals, Inc. and Takeda.
Faculty/speakers here...
Planners and Reviewers
Dorothy Caputo, MA, BSN, RN (President, AKH Inc.)
Michele Bielarski, RN (Reviewer)
Bernadette Makar, MSN, APRN-BC, NP-C (Reviewer)
AKH Inc Staff and Planners
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Clinical CME Group, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 10.75 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Credit being awarded: 10.75 ANCC contact hours
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Clinical CME Group, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 10.75 contact hour(s) (which includes XX hour(s) of pharmacology).
Available Credit
- 10.75 AANP
- 10.75 AMA PRA Category 1 Credit™
- 10.75 ANCC
- 10.75 Attendance